Home / World Marketplace / Archive by category Global Health & Biotech (Page 12)

Archive by category Global Health & Biotech

EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen

Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward WALTHAM, Mass. and ERLANGEN, Germany and LUDWIGSHAFEN, Germany, Sept. 03, 2025 (Korea Bizwire) – Siemens Healthineers, a leading global medical technology company, and Evident — which recently acquired Pramana, an AI-enabled health tech company modernizing the pathology sector — announced a [...]

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery. European debut planned for 2025 Global ophthalmic congresses in Europe (Euretina and ESCRS). WALTHAM, Mass., Sept. 03, 2025 (Korea Bizwire) – BVI, a leading global ophthalmic device company dedicated to sitting at the [...]

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (Korea Bizwire) — Persephoni BioSciences LLC (“Persephoni”), a leading global life sciences venture studio, is proud to announce a $1.5 million sponsorship to American Cancer Society BrightEdge LLC (“BrightEdge”) in support of its innovation acceleration programs. As a leading sponsor, Persephoni and BrightEdge will also develop a strategic [...]

WeightWatchers Advances International Growth With Strategic Leadership Appointment

Alejandro Bethlen to Lead WeightWatchers’ Next Phase of International Growth and Innovation, Building on More Than 50 Years in Global Markets NEW YORK, Sept. 03, 2025 (Korea Bizwire) — WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice [...]

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

TEL AVIV, Israel, Sept. 02, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at two upcoming investor conferences in September as follows: Morgan Stanley 23rd Annual Global Healthcare Conference Tuesday, September 9, 2025, at 8:30 A.M. ET BofA Global Healthcare [...]

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager

VANCOUVER, British Columbia, Sept. 02, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced its decision to voluntarily discontinue clinical development of ZW171, a T cell engager designed to [...]

Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been approved based on an objective response rate of 71% (N=75), as demonstrated in the Beamion-LUNG 1 clinical trial1 Zongertinib recently received Breakthrough Therapy Designation for the first-line treatment of advanced HER2-mutant NSCLC by the Center for Drug Evaluation (CDE) Boehringer [...]

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s continued commitment to its complex generic medicine portfolio as part of its Pivot to Growth Strategy. Liraglutide injection is indicated for adults with obesity or overweight [...]

iHerb Reaches 29-Year Milestone with Global Anniversary Sale

Global e-commerce leader in Health and Wellness celebrates with 29% off discounts, launches new house brands products, and expands international reach with 14 additional languages IRVINE, Calif., Aug. 28, 2025 (Korea Bizwire) – iHerb, one of the world’s largest online retailers specializing in health and wellness, is celebrating its 29th anniversary with its biggest, month-long sales [...]

AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025

MILAN, Aug. 28, 2025 (Korea Bizwire) – AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated LUCE-1 clinical data at the 25th European Society of Retina Specialists (EURETINA) Annual Congress (EURetina 2025), taking place in Paris 4-7 September 2025. AAVantgarde will also be presenting at the [...]